2009 annual financial data
Nektar Therapeutics 2009 Net margin
Direct answer
Net margin was -142.52%.
Operating income was -95,132,000 USD and net income was -102,519,000 USD.
Operating cash flow was 39,739,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 71,931,000 USD
- Operating income
- -95,132,000 USD
- Net income
- -102,519,000 USD
- Operating cash flow
- 39,739,000 USD